Therapeutic Asset Ratings
191 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
FLUDEOXYGLUCOSE
Head And Neck Carcinoma
Jonsson Comprehensive Cancer Center
P1
CC
(43)
FLUDEOXYGLUCOSE
IDH-Wildtype Glioblastoma
Jonsson Comprehensive Cancer Center
P1
CC
(43)
FLUDEOXYGLUCOSE
Adrenal Gland Cancer
Jonsson Comprehensive Cancer Center
P1
CC
(43)
FLUDEOXYGLUCOSE
Malignant Neoplasm of Unknown Primary
Jonsson Comprehensive Cancer Center
P1
CC
(43)
FLUDEOXYGLUCOSE
Testicular Cancer
Jonsson Comprehensive Cancer Center
P1
CC
(43)
FLUDEOXYGLUCOSE
Uterine Cancer
Jonsson Comprehensive Cancer Center
P1
CC
(43)
FLUDEOXYGLUCOSE
Penile Carcinoma
Jonsson Comprehensive Cancer Center
P1
CC
(43)
FLUDEOXYGLUCOSE
Pleural Neoplasm
Jonsson Comprehensive Cancer Center
P1
CC
(43)
FLUDEOXYGLUCOSE
Astrocytoma (Excluding Glioblastoma)
Jonsson Comprehensive Cancer Center
P1
CC
(43)
FLUDEOXYGLUCOSE
Salivary Gland Carcinoma
Jonsson Comprehensive Cancer Center
P1
CC
(43)
FLUDEOXYGLUCOSE
Skin Carcinoma
Jonsson Comprehensive Cancer Center
P1
CC
(43)
FLUDEOXYGLUCOSE
Solitary Fibrous Tumor
Jonsson Comprehensive Cancer Center
P1
CC
(43)
FLUDEOXYGLUCOSE
Thymic Carcinoma
Jonsson Comprehensive Cancer Center
P1
CC
(43)
FLUDEOXYGLUCOSE
Medullary Thyroid Gland Carcinoma
Jonsson Comprehensive Cancer Center
P1
CC
(43)
FLUDEOXYGLUCOSE
Vaginal Carcinoma
Jonsson Comprehensive Cancer Center
P1
CC
(43)
Ligritinib
Pancreatic Ductal Adenocarcinoma
Jonsson Comprehensive Cancer Center
P1
CC
(43)
Ligritinib
Cholangiocarcinoma
Jonsson Comprehensive Cancer Center
P1
CC
(43)
Ligritinib
Malignant Pancreatic Neoplasm
Jonsson Comprehensive Cancer Center
P1
CC
(43)
Pembrolizumab
Urinary Bladder Small Cell Neuroendocrine Carcinoma
Jonsson Comprehensive Cancer Center
P1
CC
(43)
Pembrolizumab
Prostate Neuroendocrine Neoplasm
Jonsson Comprehensive Cancer Center
P1
CC
(43)
Pembrolizumab
Ureter Small Cell Carcinoma
Jonsson Comprehensive Cancer Center
P1
CC
(43)
Tocilizumab
B-Cell Chronic Lymphocytic Leukemia
Jonsson Comprehensive Cancer Center
P1
CC
(43)
Tocilizumab
CD19 Positive
Jonsson Comprehensive Cancer Center
P1
CC
(43)
Tocilizumab
CD20 Positive
Jonsson Comprehensive Cancer Center
P1
CC
(43)
Zimberelimab
Pancreatic Ductal Adenocarcinoma
Jonsson Comprehensive Cancer Center
P1
CC
(43)
Showing 151 to 175 of 191 assets
Previous
Page 7 of 8
Next
